ArticleEuropean journal of pediatrics2025
Comprehensive clinical and genetic characterization of Bardet-Biedl Syndrome: insights from the largest Turkish cohort.
Article in European journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bardet-Biedl Syndrome (BBS) is a rare, pleiotropic ciliopathy involving retinal dystrophy, polydactyly, obesity, and renal abnormalities. Despite growing knowledge of its genetic basis, data from populations with high rates of consanguinity remain limited. This study presents the largest genetically confirmed BBS cohort reported from Türkiye, consisting of 25 individuals who underwent clinical exome-based multigene panel testing. Biallelic pathogenic variants were identified in all patients, including three novel variants in the ARL6/BBS3, BBS9, and BBS10 genes, observed in four patients, including two siblings. Retinal dystrophy was the most common feature (94.1%), followed by polydactyly (88.0%), obesity (68.0%), and renal anomalies (52.0%). Genotype-phenotype comparisons highlighted notable variability, particularly among individuals with BBS1 and BBS10 pathogenic variants, consistent with prior international cohorts. This cohort underscores the clinical heterogeneity of BBS and reveals potential population-specific patterns shaped by consanguinity and genetic background. Our findings support the utility of multigene panels in clinical diagnosis and provide a basis for national registries and targeted care strategies for rare inherited diseases in underrepresented populations.
Indexed as
Identifiers
41219488What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.